Literature DB >> 18298551

Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function.

Shalini Gupta1, Ramanamurthy Boppana, Gyan C Mishra, Bhaskar Saha, Debashis Mitra.   

Abstract

The mechanism of the T-cell response and cytokine induction to restrict human immunodeficiency virus 1 (HIV-1) infection is not clear. During early infection, HIV-infected individuals have a high frequency of virus-specific cytotoxic T lymphocytes (CTLs) that effectively reduces the viral load. However, the CTLs are unable to clear the virus at later stages of infection, leading to disease progression. Dysregulation of cytokines like interleukin-12 (IL-12) and interferon-gamma (IFN-gamma) as a result of the interaction of HIV-1-specific T cells with antigen-presenting cells is one of the possible causes of CTL dysfunction. Secretion of IL-12 is reduced with the progression of HIV infection, correlating with impaired CTL function; however, the role of IL-12 in CTL regulation awaits elucidation. Here, we have studied the role of IL-12 in CTL dysfunction by using DNA immunization of wild-type (WT) and IL-12-deficient mice with HIV-1 gp120 complementary DNA. It was observed that the CTL response in IL-12-deficient mice was significantly less than that in WT mice. Our results further demonstrated that coimmunization with IL-12 vector restored the impaired CTL response in IL-12-deficient mice. However, immunization with IL-12 vector failed to rescue the CTL response in IFN-gamma deficient mice, suggesting that the CTL-promoting function of IL-12 is IFN-gamma-mediated. Our data suggest a phase-specific role of IL-12 in the CTL response, specifically in the priming of CD4+ T cells that provide help to CD8+ T cells. Our results also suggest that IL-12 is vital for the priming of antigen-specific T cells and plays an essential role in IFN-gamma induction in T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298551      PMCID: PMC2492947          DOI: 10.1111/j.1365-2567.2008.02809.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  44 in total

1.  Expression and purification of glutathione S-transferase-tagged HIV-1 gp120: no evidence of an interaction with CD26.

Authors:  Y H Wang; A H Davies; I M Jones
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

2.  Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells.

Authors:  Tatsuyoshi Kawamura; Hiroyuki Gatanaga; Debra L Borris; Mark Connors; Hiroaki Mitsuya; Andrew Blauvelt
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

3.  The role of T cell help for anti-viral CTL responses.

Authors:  D Wodarz; V A Jansen
Journal:  J Theor Biol       Date:  2001-08-21       Impact factor: 2.691

4.  A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection.

Authors:  Mark A Jacobson; John Spritzler; Alan Landay; Ellen Chan; David Katzenstein; Barbara Schock; Lawrence Fox; JoanaD'arc Roe; Smriti Kundu; Richard Pollard
Journal:  AIDS       Date:  2002-05-24       Impact factor: 4.177

5.  Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.

Authors:  J D Boyer; A D Cohen; K E Ugen; R L Edgeworth; M Bennett; A Shah; K Schumann; B Nath; A Javadian; M L Bagarazzi; J Kim; D B Weiner
Journal:  AIDS       Date:  2000-07-28       Impact factor: 4.177

6.  Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS.

Authors:  Stefan Kostense; Kristin Vandenberghe; Jeanine Joling; Debbie Van Baarle; Nening Nanlohy; Erik Manting; Frank Miedema
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

7.  Restoration of anti-human immunodeficiency virus type 1 (HIV-1) responses in CD8+ T cells from late-stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein-loaded dendritic cells.

Authors:  Z Fan; X L Huang; L Borowski; J W Mellors; C R Rinaldo
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 8.  Functional significance of the perforin/granzyme cell death pathway.

Authors:  Joseph A Trapani; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

9.  HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.

Authors:  V Appay; D F Nixon; S M Donahoe; G M Gillespie; T Dong; A King; G S Ogg; H M Spiegel; C Conlon; C A Spina; D V Havlir; D D Richman; A Waters; P Easterbrook; A J McMichael; S L Rowland-Jones
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

View more
  3 in total

Review 1.  Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV).

Authors:  Sergio Rosales-Mendoza; Néstor Rubio-Infante; Dania O Govea-Alonso; Leticia Moreno-Fierros
Journal:  Plant Cell Rep       Date:  2011-12-13       Impact factor: 4.570

2.  Ex vivo nicotine stimulation augments the efficacy of human peripheral blood mononuclear cell-derived dendritic cell vaccination via activating Akt-S6 pathway.

Authors:  Yan Yan Wang; Yi Wen Yang; Xiang You; Xiao Qian Deng; Chun Fang Hu; Cong Zhu; Jun Yao Wang; Jiao Jiao Gu; Yi Nan Wang; Qing Li; Feng Guang Gao
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-13       Impact factor: 2.916

3.  Coordinated regulation of SIV replication and immune responses in the CNS.

Authors:  Kenneth W Witwer; Lucio Gama; Ming Li; Christopher M Bartizal; Suzanne E Queen; John J Varrone; Angela K Brice; David R Graham; Patrick M Tarwater; Joseph L Mankowski; M Christine Zink; Janice E Clements
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.